060590 — CTC Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Market Cap
KR₩90bn
Enterprise Value
KR₩116bn
Revenue
KR₩124bn

Annual balance sheet for CTC Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7,695	24,351	24,679	19,171	17,711
Net Total Accounts Receivable
Net Total Receivables	31,963	27,811	24,824	21,865	20,413
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	70,694	89,836	84,119	73,539	69,470
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	78,965	74,992	62,081	60,895	56,545
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	168,226	186,326	165,862	153,688	143,235
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	60,156	74,658	74,316	66,186	50,421
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	83,213	92,423	90,417	84,068	70,512
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	85,013	93,903	75,444	69,620	72,724
Total Liabilities & Shareholders' Equity	168,226	186,326	165,862	153,688	143,235
Total Common Shares Outstanding